CDEK
← All drugs Report issue

allogeneic adipose derived mesenchymal stem cell

Cell therapyexperimental

Clinical trial activity

336 trials · 368 clinical orgs · 0 marketing orgs

Phase 1
193
Phase 2
197
Phase 3
30
Phase 4
2

Earliest trial started Oct 1, 2001 (NCT00546988)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2003

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2005

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • adipose derived mesenchymal stem cell
  • adipose derived mesenchymal stem cells
  • adipose-derived mesenchymal stem cells
  • adipose derived regenerative cells
  • adipose-derived regenerative cells
  • adipose-derived stem cell
  • adipose derived stem cells
  • adipose derived stromal cells
  • adipose stem cell
  • allogeneic adipose derived mesenchymal stem cell
  • allogeneic adipose derived stem cells
  • allogeneic adipose-derived stem cells
  • allogeneic human mesenchymal stem cells
  • allogeneic mesenchymal human stem cells
  • allogeneic mesenchymal stem cells
  • allogeneic mesencymal stem cells
  • allogenic adipose-derived stem cells
  • allogenic adipose mesenchymal stem cell
  • allogenic adipose stem cells
  • allogenic mesenchymal stem cell
  • allogenic mesenchymal stromal cells
  • autologous adipose derived mesenchymal stem cells
  • autologous adipose derived mesenchymal stromal cells
  • autologous adipose derived regenerative cells
  • autologous adipose derived stem cells
  • autologous adipose-derived stem cells
  • autologous adipose-derived stromal cells
  • autologous adipose-derived stromal vascular fraction cells
  • autologous adipose stem cell
  • autologous adipose tissue derived mesenchymal stem cells
  • autologous bone marrow blood
  • autologous bone marrow cells
  • autologous bone marrow derived cells
  • autologous bone marrow-derived cells
  • autologous bone marrow derived mesenchymal stem cells
  • autologous bone marrow derived mesencymal stem cells
  • autologous bone marrow derived stem cell
  • autologous bone marrow derived stem cells
  • autologous bone-marrow mesenchymal stem cells
  • autologous bone marrow stem cell
  • autologous bone marrow stem cells
  • autologous human bone marrow cells
  • donor mesenchymal stem cells
  • easc
  • elixcyte
  • expanded adipose-derived stem cells
  • expanded allogeneic adipose-derived stem cells
  • expanded allogenic adipose-derived adult stem cells
  • expanded autologous adipose-derived adult stem cells
  • human mesenchymal stem cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07290946Phase 2Dec 31, 2025University of Copenhagen
NCT07106229Phase 3Nov 30, 2025Magellan Stem Cells
NCT06840275Phase 2Sep 1, 2025Cell2Cure ApS
NCT07010926Phase 2Aug 15, 2025L2 Bio, LLC
NCT07048054Phase 1/Phase 2 (Phase 2)Jul 31, 2025University of Geneva
NCT07048314Phase 1/Phase 2 (Phase 2)Jul 1, 2025The University of Texas, Dallas
NCT06905834Phase 2Jun 30, 2025Instituto Universitario de Oftalmobiología Aplicada, Spanish Clinical Research Network, University of Salamanca
NCT06828666Phase 1/Phase 2 (Phase 2)May 5, 2025Amarex Clinical Research, Britecyte
NCT06623240Phase 2Jan 31, 2025Hope Biosciences
NCT06795620Phase 1Jan 31, 2025University of Toulouse
NCT06764004Phase 1/Phase 2 (Phase 2)Jan 1, 2025Erciyes University
NCT06654193Phase 1/Phase 2 (Phase 2)Jan 1, 2025Hope Biosciences, University of Alabama, Birmingham, University of California, San Francisco, University of Texas at Houston
NCT06705023Phase 2Nov 18, 2024Government of Kazakhstan, ISAR Klinikum
NCT06570291Phase 3Oct 31, 2024WuXi
NCT06303752Phase 1/Phase 2 (Phase 2)Oct 9, 2024University of Oslo, University of Southern Denmark
NCT06488898Phase 2Jun 13, 2024Universidad Autonoma de Madrid
NCT05526001Phase 3Dec 31, 2023UnicoCell Biomed CO. LTD
NCT05996224Phase 3Oct 31, 2023Cellular Biomedicine Group Ltd.
NCT05933434Phase 1/Phase 2 (Phase 2)Oct 31, 2023Aarhus University
NCT06058572Phase 2Oct 15, 2023Tata Memorial Hospital
Showing 20 of 336 trials
Page 1 / 17

Organizations

Research & Development (368)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hope BiosciencesFor profit252522018
Universidad Autonoma de MadridAcademic/Hospital161322008
Mayo ClinicAcademic/Hospital141322013
University of MiamiAcademic/Hospital131122008
Seoul National UniversityAcademic/Hospital11542007
Anterogen Co., Ltd.For profit101032009
University of Texas at HoustonAcademic/Hospital10732009
Royan InstituteAcademic/Hospital9832008
University of CopenhagenAcademic/Hospital9822014
Kyung Hee UniversityAcademic/Hospital6032015
Sorrento Therapeutics, Inc.For profit6612021
Neurogen Brain and Spine InstituteAcademic/Hospital5522008
University of BarcelonaAcademic/Hospital5132009
University of Sao PauloAcademic/Hospital5422005
University of SevilleAcademic/Hospital5012010
University of TehranAcademic/Hospital5032008
University of ToulouseAcademic/Hospital5322009
Vinmec International HospitalAcademic/Hospital5522014
Andalusian Initiative for Advanced TherapiesAcademic/Hospital4412010
BiostarFor profit4422007
368 organizations
Page 1 / 19